Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy

被引:26
作者
Agarwal, MM
Khandelwal, N
Mandal, AK
Rana, SV
Gupta, V
Mohan, VC
Kishore, GVMK
机构
[1] Postgrad Inst Med Educ & Res, Dept Urol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Radiodiag, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Gastroenterol, Chandigarh, India
关键词
prostate carcinoma; orchidectomy; osteoporosis; computed tomography; androgen antagonists; body mass index; dietary calcium;
D O I
10.1002/cncr.21047
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND. Orchidectomy is an accepted form of androgen-deprivation therapy (ADT) for prostate carcinoma. Osteoporosis is common in elderly individuals and is accelerated by ADT. The authors studied changes in bone mineral density (BMD) after ADT and factors that affected those changes. METHODS. Fifty patients with prostatic adenocarcinoma who opted to undergo orchidectomy were studied prospectively. All patients completed 6 months of follow-up, and 20 of those patients completed 12 months of follow-up. Patients' age, weight, height, body mass index (BMI), physical activity, addiction (smoking, alcohol), dietary calcium intake, and lactose tolerance status were noted. Lumbar spinal (L1-L3) trabecular BMD was measured with quantitative computed tomography (QCT) at baseline and every 6 months for 1 year and was compared with preoperative values. The effects of various patient characteristics on preoperative BMD and changes in BMD also were analyzed. RESULTS. The mean standard deviation (SD) age of the patients was 69.5 +/- 8.1 years, BMI was 23.5 +/- 3.9 kg/m(2), dietary calcium intake was 1066.1 +/- 443.3 mg per day. Thirty-eight percent of patients were lactose intolerant. Sixty-two percent of patients were in the light weight-bearing activity group. The mean +/- SD preoperative BMD was 119.2 +/- 34.9 mg/cc, with T-scores of -1.77 +/- 1.22 and Z-scores of 0.43 +/- 1.27. A decrease in BMD during the first 6 months (approximate to 13%) was statistically significant (P = 0.0001) and continued further during next 6 months (BMD loss of approximate to 18% at 12 months). Patients with osteoporosis, as defined by T-scores <= -2.5, increased from 24% at baseline to 48% at 6 months. Nonsmokers, nonalcoholics, patients with higher physical activity, and patients with a BMI > 25 kg/m(2) had statistically significant higher BMD compared with their counterparts (P < 0.05). Body weight < 60 kg and BMI < 25 kg/m(2) were significant risk factors for loss of BMD (P < 0.05). Dietary calcium had a discernible but statistically insignificant effect on BMD (P = 0.16). Lactose intolerance had no significant effect on BMD or. bone loss. CONCLUSIONS. Osteoporosis was common in the population affected by prostate carcinoma. Orchidectomy led to accelerated bone loss. Periodic measurement of BMD after ADT would help in the early detection of osteoporosis. Maintenance of high BMI, weight-bearing physical activity, avoidance of alcohol and smoking, and possibly high dietary calcium intake help in maintaining bone mass. (c) 2005 American Cancer Society.
引用
收藏
页码:2042 / 2052
页数:11
相关论文
共 59 条
[1]
AHMED SR, 1983, LANCET, V2, P415
[2]
AKESSON K, 1995, J BONE MINER RES, V10, P1823
[3]
[Anonymous], 1994, JAMA, V272, P1942
[4]
FACTORS ASSOCIATED WITH APPENDICULAR BONE MASS IN OLDER WOMEN [J].
BAUER, DC ;
BROWNER, WS ;
CAULEY, JA ;
ORWOLL, ES ;
SCOTT, JC ;
BLACK, DM ;
TAO, JL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :657-665
[5]
EFFECTS OF TOTAL AND SUBCAPSULAR ORCHIDECTOMY ON SERUM CONCENTRATIONS OF TESTOSTERONE AND PITUITARY-HORMONES IN PATIENTS WITH CARCINOMA OF THE PROSTATE [J].
BERGMAN, B ;
DAMBER, JE ;
TOMIC, R .
UROLOGIA INTERNATIONALIS, 1982, 37 (02) :139-144
[6]
Background to and management of treatment-related bone loss in prostate cancer [J].
Berruti, A ;
Tucci, M ;
Terrone, C ;
Gorzegno, G ;
Scarpa, RM ;
Angeli, A ;
Dogliotti, L .
DRUGS & AGING, 2002, 19 (12) :899-910
[7]
Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy [J].
Berruti, A ;
Dogliotti, L ;
Terrone, C ;
Cerutti, S ;
Isaia, G ;
Tarabuzzi, R ;
Reimondo, G ;
Mari, M ;
Ardissone, P ;
De Luca, S ;
Fasolis, G ;
Fontana, D ;
Rossetti, SR ;
Angeli, A .
JOURNAL OF UROLOGY, 2002, 167 (06) :2361-2367
[8]
HORMONAL PATTERN IN PROSTATIC CARCINOMA FOLLOWING ORCHIDECTOMY - 5-YEAR FOLLOW-UP [J].
BRACCI, U ;
DISILVERIO, F ;
SCIARRA, F ;
SORCINI, G ;
PIRO, C ;
SANTORO, F .
BRITISH JOURNAL OF UROLOGY, 1977, 49 (02) :161-166
[9]
CAPS MW, 1991, NZ MED J, V104, P417
[10]
CLARKE N W, 1991, European Urology, V19, P114